This research aimed to evaluate the effectiveness of transcranial magnetic stimulation in alleviating pain and depressive symptoms in patients with postherpetic neuralgia.
Conducted a randomized controlled trial (ChiCTR2500096978).
Included patients with postherpetic neuralgia and comorbid depression.
Evaluated the impact of transcranial magnetic stimulation on pain and depression.
Transcranial magnetic stimulation significantly reduced pain intensity and depressive symptoms.
Results indicate a positive effect on the quality of life for participants undergoing treatment.
Abstract
Chinese Clinical Trial Register Identifier: ChiCTR2500096978.